Viscum Salix Rk 23x

Dosage for Viscum Album Whole is highly individualized and depends entirely on the clinical objective (diagnostic vs. therapeutic) and the specific product concentration.

• For Diagnostic Skin Prick Testing: Healthcare providers typically use a single drop of a 1:10 or 1:20 w/v extract applied to the forearm or back, followed by a skin prick. Results are read after 15 to 20 minutes.
• For Intradermal Testing: If the skin prick test is negative, a small volume (0.02 mL to 0.05 mL) of a more dilute extract (e.g., 1:1000 w/v) may be injected into the dermis.
• For Homeopathic Use: Dosages vary widely. A common regimen might include 5-10 drops of a 3X to 6X dilution taken three times daily. However, these preparations are not standardized for active lectin content.

Viscum Album Whole is not generally recommended for use in children unless specifically directed by an allergist for diagnostic purposes.

• Safety Profile: The safety and efficacy of mistletoe extracts in the pediatric population have not been established through rigorous clinical trials.
• Dosing: If used for allergy testing, pediatric dosing follows adult protocols but requires smaller volumes and more cautious monitoring for systemic reactions.

Renal Impairment

No specific dosage adjustments are provided by manufacturers for patients with kidney disease. However, because protein degradation products are cleared renally, clinicians should monitor for increased local sensitivity in patients with end-stage renal disease (ESRD).

Hepatic Impairment

As Viscum Album Whole does not rely on hepatic CYP450 metabolism, liver impairment is not expected to significantly alter the pharmacokinetics of the extract. Nevertheless, patients with autoimmune-related liver conditions should be monitored closely for immune flare-ups.

Elderly Patients

Geriatric patients may have thinner skin and a diminished immune response, which can lead to false-negative results in diagnostic testing. Dosage should be based on clinical judgment, starting with the lowest possible concentration to avoid systemic irritation.

• Administration: Injectable forms must be administered by a healthcare professional in a clinical setting equipped with emergency resuscitation equipment (e.g., epinephrine, oxygen).
• Site Selection: For subcutaneous use, sites should be rotated (upper arms, thighs, or abdomen) to prevent localized tissue hardening (induration).
• Timing: Diagnostic testing should be performed when the patient is not experiencing acute allergy symptoms and has avoided antihistamines for at least 48-72 hours.
• Storage: Most extracts must be stored under refrigeration (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light to prevent protein degradation.

If a dose of a prescribed mistletoe regimen is missed, patients should contact their provider. In the context of allergenic immunotherapy, a missed dose may require a 'step-back' in concentration to prevent an adverse reaction when treatment resumes. Do not double the dose to catch up.

An overdose of Viscum Album Whole, particularly via injection, can lead to severe systemic reactions.

• Signs: Rapid heartbeat, generalized hives (urticaria), swelling of the throat (angioedema), difficulty breathing, and a sharp drop in blood pressure (hypotension).
• Emergency Measures: Immediate administration of epinephrine (0.3 mg IM for adults) and transfer to an emergency department. In cases of accidental ingestion of large quantities of the raw plant or concentrated extract, gastric lavage and activated charcoal may be required to prevent lectin-induced gastrointestinal toxicity.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or administration schedule without explicit medical guidance.

When administered via injection, local reactions are the most frequently reported side effect.

• Injection Site Reactions: Redness (erythema), itching (pruritus), and swelling (edema) at the site of administration. This is often considered a positive sign that the immune system is responding to the extract.
• Fever and Chills: A mild rise in body temperature (up to 101°F) is common within 12 hours of administration, particularly with therapeutic extracts. This is often accompanied by a general feeling of malaise or 'flu-like' symptoms.
• Local Lymph Node Swelling: Mild tenderness or enlargement of lymph nodes near the injection site.

• Headache: Persistent dull aching following administration.
• Fatigue: Significant tiredness that may last for 24-48 hours.
• Gastrointestinal Upset: Mild nausea or abdominal cramping, though this is more common with oral homeopathic forms than with injections.
• Dizziness: Lightheadedness immediately following the injection, which may be vasovagal (fainting response) or a mild systemic reaction.

• Granuloma Formation: Small, firm bumps under the skin at the injection site that may persist for weeks.
• Urticaria (Hives): Generalized itchy welts appearing on parts of the body far from the injection site.
• Joint Pain (Arthralgia): Temporary aching in the joints, possibly due to circulating immune complexes.

> Warning: Stop taking Viscum Album Whole and call your doctor immediately or seek emergency care if you experience any of the following:

• Anaphylaxis: This is a life-threatening allergic reaction. Symptoms include a sudden feeling of doom, swelling of the tongue or throat, wheezing, extreme difficulty breathing, and fainting.
• Severe Hypotension: A sudden drop in blood pressure characterized by cold, clammy skin and a rapid, weak pulse.
• Chest Pain: Any tightness or pressure in the chest, which could indicate a rare cardiovascular stress response to the extract.
• Neurological Changes: Confusion, seizures, or extreme vertigo.

Because Viscum Album Whole is an immunomodulator, prolonged use may theoretically lead to changes in the immune profile.

• Autoimmune Triggering: There is a theoretical risk that chronic immune stimulation could exacerbate pre-existing autoimmune conditions (e.g., rheumatoid arthritis or lupus).
• Persistent Induration: Chronic subcutaneous injections in the same area can lead to localized lipodystrophy (changes in fat tissue) or permanent skin discoloration.

No FDA black box warnings for Viscum Album Whole. However, standard warnings for allergenic extracts apply, emphasizing that they should only be administered by clinicians prepared to treat anaphylaxis.

Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of the injection site and systemic temperature is recommended during the first 24 hours after a dose.

Viscum Album Whole is a potent biological substance. It must never be used interchangeably with other mistletoe species (such as American Mistletoe, Phoradendron leucarpum), as the chemical profiles and toxicities differ significantly. Patients with a known history of severe allergies to other members of the Santalaceae family should exercise extreme caution.

There are currently no FDA-mandated black box warnings specifically for Viscum Album Whole. However, it falls under the general safety guidelines for all Non-Standardized Allergenic Extracts, which mandate administration in a controlled medical environment due to the risk of sudden, severe allergic reactions.

• Anaphylaxis Risk: The most significant risk associated with Viscum Album Whole is a systemic allergic reaction. Patients must remain in the doctor's office for at least 30 minutes following an injection to be monitored for signs of respiratory distress or circulatory collapse.
• Acute Inflammatory Conditions: Viscum Album Whole should not be administered during an acute febrile illness (high fever) or an active inflammatory flare-up. The extract may exacerbate the inflammatory cascade.
• Chronic Infections: There is concern that immunomodulatory extracts could interfere with the body's management of chronic infections like tuberculosis (TB) or certain viral hepatitides. Use with caution in these populations.
• Hyperthyroidism: Some reports suggest that mistletoe extracts may stimulate thyroid activity. Patients with uncontrolled hyperthyroidism should avoid this extract unless cleared by an endocrinologist.

Patients undergoing long-term therapy or repeated diagnostic testing should have the following monitored:

• Complete Blood Count (CBC): To monitor for changes in white blood cell counts (eosinophilia or lymphocytosis).
• Injection Site Assessment: To ensure no development of necrotic tissue or severe granulomas.
• Temperature Logs: If used therapeutically, patients should track their basal body temperature to ensure the 'mistletoe fever' remains within a safe range.

Viscum Album Whole may cause dizziness or fatigue shortly after administration. Patients should avoid driving or operating heavy machinery for at least several hours following an injection until they know how the medication affects them.

While there is no direct chemical interaction between alcohol and Viscum Album Whole, alcohol consumption can dilate blood vessels and potentially increase the rate of absorption of the extract, thereby increasing the risk of a systemic allergic reaction. It is advised to avoid alcohol on the day of administration.

There is no known withdrawal syndrome associated with stopping Viscum Album Whole. However, if used for desensitization, stopping abruptly will result in the loss of any accumulated immunological tolerance.

> Important: Discuss all your medical conditions, including any history of asthma or autoimmune disease, with your healthcare provider before starting Viscum Album Whole.

• Live Vaccines: Viscum Album Whole should not be administered concurrently with live attenuated vaccines (e.g., MMR, Varicella). The immunomodulatory effects of the mistletoe extract may interfere with the vaccine's ability to produce a controlled immune response, potentially leading to increased vaccine side effects or reduced efficacy.
• Non-Selective MAO Inhibitors: There is a theoretical risk of hypertensive crisis if concentrated mistletoe extracts (which contain tyramine-like substances) are used with MAOIs. While rare with modern extracts, this combination should be avoided.

• Immunosuppressants: Drugs such as cyclosporine, tacrolimus, and high-dose corticosteroids (prednisone) work by suppressing the immune system. Since Viscum Album Whole is intended to stimulate or modulate the immune system, these medications may neutralize the effects of the extract. Conversely, the extract may reduce the effectiveness of the immunosuppressant in organ transplant or autoimmune patients.
• Beta-Blockers: Patients taking beta-blockers (e.g., metoprolol, propranolol) may be resistant to the effects of epinephrine. If an allergic reaction to Viscum Album Whole occurs, it may be much more difficult to treat.

• Antihistamines: Drugs like cetirizine, loratadine, and diphenhydramine will suppress the skin's reaction to Viscum Album Whole, leading to false-negative results in diagnostic allergy testing. These should be discontinued several days prior to testing.
• Tricyclic Antidepressants (TCAs): Similar to beta-blockers, TCAs may potentiate the cardiovascular response during an allergic reaction, complicating emergency management.

• Tyramine-Rich Foods: High concentrations of tyramine (found in aged cheeses, cured meats, and red wine) could theoretically interact with the alkaloids in mistletoe, though this is unlikely at standard diagnostic or homeopathic doses.
• Caffeine: High caffeine intake may mask the sedative or dizzying side effects of the extract, potentially leading to over-exertion following a dose.

• Echinacea and Goldenseal: These immunostimulatory herbs may have additive effects with Viscum Album Whole, potentially leading to an overactive immune response or increased inflammation.
• St. John’s Wort: While primarily a CYP3A4 inducer, its complex effects on neurotransmitters may interact with the general systemic effects of mistletoe alkaloids.

• Skin Prick Tests: As noted, antihistamines and certain antidepressants will interfere with the results.
• Total IgE Levels: Long-term use of allergenic extracts may cause a transient rise in total serum IgE levels, which could be misinterpreted in other diagnostic contexts.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications.

Viscum Album Whole must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any patient who has previously experienced anaphylaxis or a severe systemic reaction to European Mistletoe or its components.
• Acute Infectious Diseases: Patients with high fever, sepsis, or acute inflammatory conditions (e.g., acute pneumonia) should not receive the extract, as it may worsen the systemic inflammatory response.
• Active Tuberculosis: There is historical and clinical concern that mistletoe extracts can cause a reactivation or worsening of tuberculosis by altering the granulomatous immune response.
• Intracranial Tumors: In some clinical guidelines, mistletoe is contraindicated in patients with primary brain tumors or brain metastases due to the theoretical risk of peritumoral edema (swelling around the tumor) caused by immune stimulation.

Conditions requiring a careful risk-benefit analysis include:

• Autoimmune Disorders: Conditions like Multiple Sclerosis (MS), Systemic Lupus Erythematosus (SLE), and Rheumatoid Arthritis (RA) may be exacerbated by immune stimulation. Use must be closely monitored by a specialist.
• Hyperthyroidism: Because mistletoe may have metabolic-stimulating properties, patients with Graves' disease or toxic multinodular goiter should be stabilized before use.
• Pregnancy: Due to the lack of safety data and the potential for uterine-stimulating effects of viscotoxins, use is generally avoided unless the diagnostic need is critical.

Patients allergic to other members of the Santalaceae family or those with broad 'weed and tree' pollen allergies may exhibit cross-reactivity. There is also documented cross-reactivity between mistletoe lectins and certain other plant lectins (such as those found in castor beans, though the latter is far more toxic).

> Important: Your healthcare provider will evaluate your complete medical history, including any history of autoimmune disease or chronic infection, before prescribing or administering Viscum Album Whole.

Viscum Album Whole is generally categorized as Pregnancy Category C (or unclassified in many systems). There are no adequate and well-controlled studies in pregnant women. Animal studies have suggested that high doses of mistletoe viscotoxins may have oxytocic effects (causing uterine contractions). Therefore, Viscum Album Whole should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It is typically avoided during the first trimester to minimize any risk to organogenesis.

It is unknown whether the components of Viscum Album Whole, such as lectins or viscotoxins, are excreted in human milk. Because many proteins are destroyed in the infant's digestive tract, systemic absorption by the nursing infant is unlikely but not impossible. The risk of hypersensitivity in the infant must be considered. Consult a healthcare provider before breastfeeding while using this extract.

The safety and effectiveness of Viscum Album Whole in pediatric patients have not been established. In Europe, mistletoe extracts are sometimes used in children for specific indications under strict specialist supervision, but this is not standard practice in the United States. Diagnostic use for allergy is permissible if performed by a pediatric allergist.

Clinical studies have not identified significant differences in responses between elderly and younger patients. However, elderly patients are more likely to have co-morbidities (like heart disease) that could make an anaphylactic reaction more dangerous. Furthermore, age-related decline in skin reactivity may lead to false-negative diagnostic results. Dose titration should be conservative.

Specific studies in patients with renal impairment have not been conducted. While the large proteins are not filtered by the glomerulus, their breakdown products are. Patients with a GFR < 30 mL/min should be monitored for unusually prolonged local reactions or systemic malaise.

No dosage adjustment is typically required for hepatic impairment. However, patients with autoimmune hepatitis should avoid Viscum Album Whole due to the risk of stimulating an immune attack on the liver.

> Important: Special populations require individualized medical assessment. Always inform your provider if you are pregnant, planning to become pregnant, or nursing.

Viscum Album Whole acts as a complex biological response modifier. Its primary molecular targets are:

1. 1Ribosomes: Mistletoe Lectin I (ML-I) binds to cell surface receptors and is internalized. The A-chain then inactivates the 60S ribosomal subunit by removing a specific adenine residue from the 28S rRNA. This irreversibly inhibits protein synthesis, leading to cell death.
2. 2Cell Membranes: Viscotoxins (thionins) are amphipathic molecules that insert themselves into the lipid bilayer of cell membranes. This creates transmembrane pores, leading to ion imbalance, loss of membrane integrity, and rapid cytolysis.
3. 3Cytokine Induction: The extract stimulates monocytes and macrophages to release cytokines, including Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), which mediate the systemic 'flu-like' response and fever.

The pharmacodynamic effect is characterized by a biphasic immune response. Initially, there is a pro-inflammatory phase (fever, local swelling) followed by an adaptive phase where T-cell activity and Natural Killer (NK) cell cytotoxicity are enhanced. The duration of effect for a single dose on the immune system can range from 48 hours to several days.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Subcutaneous); <1% (Oral) |

| Protein Binding | Extensive (to serum glycoproteins) |

| Half-life | 2 - 4 hours (Lectin components) |

| Tmax | 1 - 2 hours (Local tissue peak) |

| Metabolism | Proteolysis (Proteasomal degradation) |

| Excretion | Renal (as peptides/amino acids) |

• Molecular Components: A mixture of glycoproteins (lectins), polypeptides (viscotoxins), polysaccharides, and alkaloids.
• Solubility: Soluble in aqueous solutions (saline, water for injection).
• Structure: The lectins are heterodimeric proteins (approx. 60 kDa). Viscotoxins are small cysteine-rich proteins (approx. 5 kDa).

Viscum Album Whole belongs to the class of Non-Standardized Plant Allergenic Extracts. It is grouped with other botanical extracts used for diagnostic and immunotherapeutic purposes, such as grass, weed, and tree pollen extracts.